MoneyWorks4Me

RPG Life Sciences - Quaterly Results

29 Oct 2021 Evaluate
The revenue for the September 2021 quarter is pegged at Rs. 1126.50 millions, about 15.98% up against Rs. 971.30 millions recorded during the year-ago period.Net Profit recorded in the quarter ended September 2021 rise to 41.26% to Rs. 157.50  millions  compared to R. 111.50 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 265.10 millions from 191.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1126.50 971.30 15.98 2207.80 1887.80 16.95 3891.40 3755.70 3.61
Other Income 7.10 0.40 1675.00 11.20 4.90 128.57 9.10 7.30 24.66
PBIDT 265.10 191.60 38.36 498.70 364.60 36.78 708.40 598.80 18.30
Interest 1.70 2.30 -26.09 3.00 5.40 -44.44 7.90 17.50 -54.86
PBDT 263.40 189.30 39.14 495.70 359.20 38.00 700.50 528.10 32.65
Depreciation 39.90 42.00 -5.00 79.50 83.60 -4.90 164.70 163.60 0.67
PBT 223.50 147.30 51.73 416.20 275.60 51.02 535.80 364.50 47.00
TAX 66.00 35.80 84.36 122.90 73.50 67.21 135.80 74.40 82.53
Deferred Tax -1.00 -11.50 -91.30 -1.90 -14.90 -87.25 -35.70 -26.60 34.21
PAT 157.50 111.50 41.26 293.30 202.10 45.13 400.00 290.10 37.88
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.53 19.73 19.30 22.59 19.31 16.95 18.20 15.94 14.18
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..